Antimicrobial Resistance During the SARS-CoV-2 (COVID-19) Pandemic

Description

Assess the incidence and rates of resistant pathogens prior to and during the COVID-19 pandemic.

Conditions

COVID-19

Talk to us

Study Overview

On this page

Study Details

Study overview

Assess the incidence and rates of resistant pathogens prior to and during the COVID-19 pandemic.

What Happened? Antimicrobial Resistance During the SARS-CoV-2 (COVID-19) Pandemic

Antimicrobial Resistance During the SARS-CoV-2 (COVID-19) Pandemic

Condition
COVID-19
Intervention / Treatment

-

Contacts and Locations

Dallas

Methodist Dallas Medical Center, Dallas, Texas, United States, 75203

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * • Patients admitted to Methodist Richardson, Methodist Mansfield, Methodist Charlton, or Methodist Dallas Medical Centers between March 2018 and August 2021.
  • * \>18 years old
  • * • Outpatient visit
  • * Not admitted to an inpatient or observation status

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Methodist Health System,

Mathew Crotty, PharmD, PRINCIPAL_INVESTIGATOR, Methodist Dallas Medical Center

Study Record Dates

2024-12